These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2346170)

  • 1. Ceftriaxone-associated neutropenia.
    Billstein SA; Sudol TE
    Am J Med; 1990 Jun; 88(6):701-2. PubMed ID: 2346170
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutropenia during therapy with ceftriaxone.
    Thomas MG; Peat B; Lang SD
    N Z Med J; 1985 Jan; 98(771):23-4. PubMed ID: 3855513
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftriaxone-associated neutropenia.
    Baciewicz AM; Skiest DJ; Weinshel EL
    Drug Intell Clin Pharm; 1988 Oct; 22(10):826-7. PubMed ID: 3229355
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftriaxone-induced agranulocytosis.
    Reichman N; Raz R; Schlaeffer F; Elias M; Flatau E
    Isr J Med Sci; 1993 Jan; 29(1):52-4. PubMed ID: 8454452
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutropenia associated with cefotaxime.
    Ohsawa T; Furukawa F
    Drug Intell Clin Pharm; 1983 Oct; 17(10):739-41. PubMed ID: 6313313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute reversible agranulocytosis during ceftriaxone treatment].
    Becq-Giraudon B; Cazenave F; Breux JP
    Pathol Biol (Paris); 1986 May; 34(5):534-5. PubMed ID: 3095777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 8. Cephalosporin-induced immune neutropenia.
    Murphy MF; Metcalfe P; Grint PC; Green AR; Knowles S; Amess JA; Waters AH
    Br J Haematol; 1985 Jan; 59(1):9-14. PubMed ID: 3882133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible severe neutropenia after ceftriaxone.
    Tantawichien T; Tungsanga K; Swasdikul D
    Scand J Infect Dis; 1994; 26(1):109-10. PubMed ID: 8191231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agranulocytosis and epileptic seizure during prolonged ceftriaxone treatment].
    Vandenbos F; Baldin B; Garraffo R; Mondain-Miton V; Dellamonica P
    Ann Med Interne (Paris); 2001 Apr; 152(3):215-6. PubMed ID: 11431585
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic prophylaxis in the surgical treatment of peritrochanteric fractures: a comparative trial between two cephalosporins.
    Karachalios T; Lyritis GP; Hatzopoulos E
    Chemotherapy; 1990; 36(6):448-53. PubMed ID: 2292207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutropenia secondary to cefotaxime use].
    Burgaleta C; Parras F; Hermida JM
    Enferm Infecc Microbiol Clin; 1989; 7(7):364-7. PubMed ID: 2490462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cephalosporins of the third generation in therapy of children with severe infections].
    Samsygina GA
    Antibiot Khimioter; 2000; 45(12):32-3. PubMed ID: 11212493
    [No Abstract]   [Full Text] [Related]  

  • 18. Case 4/2011--agranulocytosis and puerperal sepsis in women after the use of ceftriaxone.
    Candido HM; Bortolotto MR; Strabelli TM; Benvenuti LA
    Arq Bras Cardiol; 2011 Aug; 97(2):e20-8. PubMed ID: 22002032
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceftriaxone-induced granulopenia related to a peculiar mechanism of granulopoiesis inhibition.
    Rey D; Martin T; Albert A; Pasquali JL
    Am J Med; 1989 Nov; 87(5):591-2. PubMed ID: 2816977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case from general practice. Agranulocytosis].
    Osterwalder P; Stocker D
    Praxis (Bern 1994); 1998 Aug; 87(33):1030-3. PubMed ID: 9747134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.